From: Economic burden of seasonal influenza B in France during winter 2010-2011
0-4 yo (n = 50) | 5-14 yo (n = 91) | 15-64 yo (n = 46) | ≥65 yo (n = 14) | All ages (n = 201) | p-value | |
---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||
Direct costs (total) | 70.0 (261.6) | 50.0 (194.8) | 33.4 (19.8) | 41.8 (18.2) | 50.6 (184.7) | <0.0003 |
Initial consultation at medical office (GP or pediatrician) | 20.7 (1.7) | 17.1 (1.6) | 15.5 (1.0) | 15.1 (0) | 17.5 (2.4) | <0.0001 |
Vaccine | 0.3 (1.3) | 0.2 (1.1) | 0.3 (1.3) | 3.6 (3.2) | 0.5 (1.7) | <0.0001 |
Follow-up consultations at medical office (GP) | 3.3 (9.0) | 3.5 (9.8) | 7.0 (11.0) | 11.9 (13.5) | 4.9 (10.4) | 0.0039 |
Follow-up at domicile (GP) | 0.5 (3.6) | 0.5 (4.8) | 1.9 (7.8) | 3.2 (11.8) | 1.0 (6.1) | 0.2718 |
Emergency services | 0.0 (0) | 1.2 (6.5) | 0.0 (0) | 0.0 (0) | 0.5 (4.4) | 0.3126 |
Hospitalization | 36.0 (254.3) | 19.8 (188.5) | 0.0 (0) | 0.0 (0) | 17.9 (179.0) | 0.7529 |
Drugs (total) | 6.5 (10.3) | 5.5 (8.8) | 5.9 (5.5) | 6.0 (6.2) | 5.9 (8.4) | 0.7705 |
Antibiotics | 0.8 (2.2) | 0.6 (1.8) | 0.8 (2.0) | 1.8 (2.9) | 0.8 (2.0) | 0.0214 |
Antivirals | 0.7 (1.5) | 0.8 (1.8) | 2.3 (3.5) | 1.1 (2.7) | 1.1 (2.4) | 0.0523 |
Other drugs | 5.0 (9.2) | 4.1 (8.5) | 2.8 (3.3) | 3.1 (3.9) | 4.0 (7.6) | 0.7518 |
Additional tests | 2.8 (11.4) | 2.2 (12.4) | 2.8 (11.2) | 2.1 (5.3) | 2.5 (11.4) | 0.5985 |
Daily allowances | 0.0 (0) | 0.0 (0) | 92.7 (174.2) | 0.0 (0) | 21.2 (91.4) | <0.0001 |
TOTAL | 70.0 (261.6) | 50.0 (194.8) | 126.1 (179.6) | 41.8 (18.2) | 71.8 (205.1) | <0.0001 |